Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is injected once a week, not once a day. Each pre-filled KwikPen contains four doses, one for each week of the month, and you use it on the same chosen day every week. That single weekly injection is enough because tirzepatide stays active in the body for seven days, gradually tapering between doses. These are prescription-only medicines; a clinician reviews your health picture before any treatment begins, and the dosing schedule is set by your prescriber, not self-selected. If you have been wondering whether you missed a daily jab — you have not. How often Mounjaro is injected is one of the most common questions our prescribers hear in the first week of treatment, and the answer is simpler than most people expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first practical step is choosing a day of the week that suits your routine, a Monday morning, a Sunday evening, whatever fits. That day becomes your injection day for the duration of treatment. Because tirzepatide's effects last seven days, consistency matters more than perfection: NHS guidance on tirzepatide on the NHS website confirms you can shift your injection day by a day or two if needed, provided you keep at least three days between doses, but your prescriber will walk you through this if it ever comes up.
One misconception worth letting go gently: some people start Mounjaro expecting to inject it the way they might take a daily tablet, each morning, religiously. It does not work that way. The medicine is designed for weekly use, and injecting it more often than prescribed would not speed results; it would simply put you outside the licensed schedule and increase the risk of side effects.
Once you have chosen your day, the pen goes back in the fridge until you need it. Rotate your injection site each week, abdomen, thigh and upper arm are all suitable locations, and there is more detail on using the upper arm as an injection site if that is your preference.
Treatment starts at 2.5 mg. That first dose exists to give your body time to adjust, not to produce immediate weight loss, its job is to reduce early nausea and help you settle into the medicine. The prescriber then increases the dose roughly every four weeks, moving through 5 mg, 7.5 mg and potentially higher, up to the licensed maximum of 15 mg, based on how you are tolerating treatment and how your weight is responding.
Throughout every step of this sequence, the injection stays weekly. The escalation changes the strength of each dose, not the frequency. NICE's appraisal of tirzepatide, TA1026, describes the titration pathway in detail for those who want to read the clinical rationale. If at any point you are unsure whether a dose increase is right for your situation, that is a conversation for your prescriber, the schedule is personalised, not one-size.
For context on what tirzepatide is and how it works at a pharmacological level, the Mounjaro overview page covers the dual GIP and GLP-1 receptor mechanism in plain language, and if you are curious about tirzepatide injection in its generic form, that page explains what the generic designation means and how it relates to the branded product.
Using the KwikPen is a relatively short process. Clean the chosen site with an alcohol swab, pinch the skin gently, press the pen against it and hold until the click confirms the dose is delivered. The full technique (including how to position the pen and how long to hold it) is covered in the step-by-step Mounjaro injection guide.
The most common effects to expect in the first day or two after each dose are gastrointestinal: nausea, occasional loose stools, or a noticeable reduction in appetite. These tend to be most pronounced after a dose increase and usually ease within a few days as the body adjusts. Staying well hydrated and eating smaller, lower-fat meals around injection day can help. If side effects feel severe or persistent, contact your prescriber rather than adjusting the dose yourself.
Storage between doses is straightforward: the pen stays refrigerated at 2–8°C. The exact window for keeping it at room temperature if refrigeration is temporarily unavailable is stated in the Patient Information Leaflet; defer to that rather than memory.
Because you are using one pen a month, treatment costs are quoted per pen or per four-week period. If you are comparing providers, it is worth reading what each price actually includes, some quote the pen cost only, with consultation fees, prescription fees and delivery added separately. There is a straightforward breakdown of what Mounjaro costs in practice, including what those headline figures often leave out, on the Mounjaro cost page.
At nume, a single transparent price covers your consultation, the clinical prescription review, the treatment itself, and free next-working-day tracked delivery. There is no subscription; each repeat order goes through a fresh clinical review by a GPhC-registered prescriber on our clinical team, not an automated system. That review checks your progress before the next pen is dispatched.
Mounjaro is a prescription-only medicine. The route to it through any legitimate UK provider (NHS or private) runs through a clinical assessment first. If you would like to find out whether you might be suitable, speak to our prescribers via a free consultation and they will review your health picture the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.